These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37387467)

  • 1. Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis.
    Timmins HC; Vucic S; Kiernan MC
    Curr Opin Neurol; 2023 Aug; 36(4):353-359. PubMed ID: 37387467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.
    Vucic S; Kiernan MC
    Neurotherapeutics; 2017 Jan; 14(1):91-106. PubMed ID: 27830492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.
    van den Bos MAJ; Geevasinga N; Higashihara M; Menon P; Vucic S
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
    Vucic S; Kiernan MC
    Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS.
    Vucic S; Pavey N; Haidar M; Turner BJ; Kiernan MC
    Neurosci Lett; 2021 Aug; 759():136039. PubMed ID: 34118310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the upper motor neuron in amyotrophic lateral sclerosis.
    Huynh W; Simon NG; Grosskreutz J; Turner MR; Vucic S; Kiernan MC
    Clin Neurophysiol; 2016 Jul; 127(7):2643-60. PubMed ID: 27291884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological and diagnostic implications of cortical dysfunction in ALS.
    Geevasinga N; Menon P; Özdinler PH; Kiernan MC; Vucic S
    Nat Rev Neurol; 2016 Nov; 12(11):651-661. PubMed ID: 27658852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease: current management and future prospects.
    Simon NG; Huynh W; Vucic S; Talbot K; Kiernan MC
    Intern Med J; 2015 Oct; 45(10):1005-13. PubMed ID: 26429216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of threshold tracking transcranial magnetic stimulation in ALS.
    Vucic S; van den Bos M; Menon P; Howells J; Dharmadasa T; Kiernan MC
    Clin Neurophysiol Pract; 2018; 3():164-172. PubMed ID: 30560220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.
    Vucic S; Ziemann U; Eisen A; Hallett M; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1161-70. PubMed ID: 23264687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological biomarkers in amyotrophic lateral sclerosis.
    Vucic S; Rutkove SB
    Curr Opin Neurol; 2018 Oct; 31(5):640-647. PubMed ID: 30080715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Transcranial Magnetic Simulation in Studying Upper Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.
    Geevasinga N; Van den Bos M; Menon P; Vucic S
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study.
    Menon P; Geevasinga N; Yiannikas C; Howells J; Kiernan MC; Vucic S
    Lancet Neurol; 2015 May; 14(5):478-84. PubMed ID: 25843898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
    Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.
    Agarwal S; Koch G; Hillis AE; Huynh W; Ward NS; Vucic S; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):47-57. PubMed ID: 29866706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability.
    Ranieri F; Mariotto S; Dubbioso R; Di Lazzaro V
    Front Neurol; 2020; 11():605335. PubMed ID: 33613416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
    Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
    JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.
    Schanz O; Bageac D; Braun L; Traynor BJ; Lehky TJ; Floeter MK
    Muscle Nerve; 2016 Aug; 54(2):264-9. PubMed ID: 26799151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies.
    Reyes-Leiva D; Dols-Icardo O; Sirisi S; Cortés-Vicente E; Turon-Sans J; de Luna N; Blesa R; Belbin O; Montal V; Alcolea D; Fortea J; Lleó A; Rojas-García R; Illán-Gala I
    Front Neurol; 2021; 12():750543. PubMed ID: 35115992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity.
    Benatar M; Granit V; Andersen PM; Grignon AL; McHutchison C; Cosentino S; Malaspina A; Wuu J
    Brain; 2022 Oct; 145(10):3500-3508. PubMed ID: 35594156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.